FDA warns consumers not to use Triaminic vapor patch
The FDA is warning consumers not to use the Triaminic Vapor Patch marketed by Novartis Consumer Health due to reports of serious adverse events associated with accidental ingestion by children. The patch contains camphor, eucalyptus oil, and menthol.
FDA warns consumers not to use Triaminic vapor patch
The FDA is warning consumers not to use the Triaminic Vapor Patch marketed by Novartis Consumer Health due to reports of serious adverse events associated with accidental ingestion by children. The patch contains camphor, eucalyptus oil, and menthol. Reported side effects from swallowing or chewing on products containing camphor or eucalyptus oils vary from burning in the mouth, to headache, nausea and vomiting, and seizures. Novartis announced it is conducting a nationwide voluntary recall of all Triaminic Vapor Patch products. The FDA is advising consumers who have used the product and have questions to contact their physician or healthcare practitioner. In addition, the company is advising consumers to either discard or return the product to point of purchase for a refund. To report adverse reactions, visit http://www.fda.gov/MedWatch/report.htm.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
Challenges for Pharmacies in 2025: What to Expect and How to Prepare
January 8th 2025Pharmacy professionals are used to overcoming obstacles in this competitive, dynamic field. But the coming year will bring challenges affecting patient care, the industry workforce and their business. Pharmacies must be ready to do more than weather the storm; they need deliberate strategy and sophisticated tools to thrive amidst these obstacles. This white paper will discuss the issues and solutions that should be at the top of every pharmacy professional’s mind as they start the new year.
